AGP Picks
View all

Wellness Daily Nauru: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.

Press releases published on July 13, 2026

Tilray Brands to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on July 28, 2026
MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
Lakefront kondigt het terugtreden van Paulo Fontoura uit de Raad van Bestuur aan na zijn benoeming tot Global Head of Research & Development bij Sanofi
Aegis Treatment Centers Opens New Medication Unit in Red Bluff, Bringing Opioid Treatment Closer to Home for Tehama County
BreathEaseX Releases Sublingual Lung Health Spray with CardioEaseX Formula for Easy Breathing Support
GutGlucose Releases Latest Ingredients List with Gut Glucose Reset Formula
Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece
Alamar Biosciences 與多間頂尖研究大學合作啟動全國計劃,旨在推動神經退行性疾病相關的血漿生物標記研究
AI Transforms Biometrics-as-a-Service in Medical Devices, Attracting $178M in Investment Activity
Good News for Hundreds of Thousands of Permanently Blind People in Vietnam
Zealand Pharma - Transactions related to share buy-back program (week 28, 2026)
ENT & Allergy Associates Welcomes Renowned Otolaryngologist and Facial Plastic Surgeon Sydney C. Butts, MD, FACS
Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy
Bavarian Nordics chikungunyavaccine indsendt til myndighedsgodkendelse i Brasilien
Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil
Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference
Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial
Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Wellness Daily Nauru

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.